Thyroid Diseases (Part II) Notes
Hyperthyroidism (Thyrotoxicosis)
Definition: state of too much thyroid hormone with elevated T3 and T4.
Types:
Primary hyperthyroidism: issue is with the thyroid gland itself (the target gland).
Secondary hyperthyroidism: issue is with the pituitary gland causing excess TSH secretion.
Other etiologies: extremely high exogenous thyroid hormone ingestion can cause a hyperthyroid picture.
Primary hyperthyroidism
Causes: thyroid tumor, autoimmune disease (Graves' disease).
Graves' disease: autoimmune stimulation of the thyroid by autoantibodies that activate TSH receptors.
Lab pattern: ↑ T3 and ↑ T4; ↓ TSH due to negative feedback; TRAB (thyrotropin receptor antibody) commonly present and can test for Graves' disease.
Graves' disease is the most common cause of thyrotoxicosis; women are ~5× more likely than men to develop Graves' disease.
Pathophysiology: autoantibody against the thyroid stimulates TSH receptors, promoting T3/T4 production.
Clinical signs/symptoms: goiter (enlarged neck), ophthalmopathy (exophthalmos, double vision, corneal disease), dermopathy (orange-peel texture of skin, especially on lower extremities).
If untreated or treated causally, the thyroid hormone remains high; negative feedback lowers TSH further (often undetectable).
Secondary hyperthyroidism
Cause: pituitary gland overproduction of TSH (e.g., pituitary tumor).
Lab pattern: ↑ T3 and ↑ T4 with ↑ or inappropriately normal/↑ TSH; TRH from hypothalamus may be suppressed due to high TSH signaling.
In the lab, TRH testing could show ↓ TRH (hypothalamus response) though in practice this test is rarely needed.
Treatments for Graves'/thyrotoxicosis (not curative, but controls signs):
Beta blockers: control symptoms like tachycardia by reducing heart rate effects of thyroid hormone.
Methimazole: inhibits thyroid hormone biosynthesis and secretion.
Radioactive iodine: destroys thyroid tissue; risks hypothyroidism thereafter requiring replacement therapy.
Surgery: thyroidectomy; preferred when thyroid cancer is suspected; can help avoid eye problems associated with radioactive iodine.
Signs focusing on Graves' disease and thyrotoxicosis
Goiter: enlarged neck due to enlarged thyroid.
Ophthalmopathy: exophthalmos or other corneal involvement; diplopia.
Dermopathy: orange-peel skin texture (pretibial myxedema) on legs.
Conceptual note on feedback and lab interpretation
Negative feedback in primary hyperthyroidism:
↑ T3/T4 → ↓ TSH caused by pituitary suppression.
Expression:
In secondary hyperthyroidism, pituitary overproduction of TSH raises T3/T4 despite feedback.
Expression:
Secondary Hyperthyroidism (pituitary-driven)
Definition: hyperthyroid state due to pituitary gland abnormality causing excess TSH secretion.
Lab pattern: ↑ TSH with ↑ T3 and ↑ T4 (positive feedback on T3/T4, though physiologically the hypothalamus will respond by reducing TRH).
Diagnostic nuance: TRH testing could show suppression of hypothalamic input; discussion focuses on distinguishing pituitary from hypothalamic causes.
Hypothyroidism
Overview: underproduction of thyroid hormones.
Types:
Primary hypothyroidism: problem lies in the thyroid gland itself.
Secondary hypothyroidism: problem lies in the pituitary gland (↓ TSH).
Tertiary hypothyroidism: problem lies in the hypothalamus (↓ TRH).
Primary hypothyroidism
Common autoimmune cause: Hashimoto's thyroiditis.
Autoantibodies: anti-TPO (thyroid peroxidase) and anti-thyroglobulin antibodies.
Lab pattern: ↓ T3 and ↓ T4; ↑ TSH due to loss of negative feedback.
Epidemiology: autoimmune disease more common in developed countries; more prevalent in middle-aged women.
Symptoms suggestsive of hypothyroidism: weight gain, fatigue, cold intolerance, hair loss, slowed heart rate, depression.
Goiter is common.
Treatment: hormone replacement with synthetic T4 (levothyroxine); T4 can be converted to T3 in vivo.
Secondary hypothyroidism
Cause: pituitary gland failure leading to ↓ TSH.
Lab pattern: ↓ T3 and ↓ T4 with ↓ TSH; hypothalamus may respond with ↑ TRH.
Possible causes: infection, stroke, tumors, or panhypopituitarism (deficiency of multiple pituitary hormones).
Tertiary hypothyroidism
Cause: hypothalamic deficiency of TRH leading to ↓ TSH and ↓ T3/T4.
Congenital hypothyroidism
Affected babies may have insufficient thyroid hormone production from birth.
Newborn screening is essential (screening around 24 hours after birth).
Early detection is crucial to prevent irreversible brain damage and mental retardation.
Treatment: lifelong thyroid hormone replacement therapy.
Laboratory testing of thyroid function (overview of tests and interpretation)
Primary approach: start with TSH measurement using sensitive assays (STSH or ultrasensitive TSH, UTSH).
If TSH is abnormal, proceed to assess thyroid hormones (free T4, total T4, free T3, total T3).
TSH monitoring is also used to follow thyroid hormone replacement therapy.
Thyroid hormones and what to measure
Free T4 (biologically active form): often the most informative single test after abnormal TSH; indicates current thyroid status.
Total T4: measures both free and bound T4; used when binding proteins are normal;
Total T4 can be affected by binding proteins (see below).
Free T3: biologically active; not as commonly measured; useful when suspecting T3 thyrotoxicosis; limited clinical use.
Total T3: affected by thyroid-binding globulin; may be used when suspecting isolated T3 abnormalities.
Binding proteins and their clinical impact
Thyroxine-binding globulin (TBG) and other binding proteins affect total hormone levels.
Increased binding proteins raise total T4; decreased binding proteins lower total T4.
Factors increasing binding proteins: estrogen therapy, pregnancy.
Factors decreasing binding proteins: drugs, renal disease, liver disease, malnutrition.
T3 uptake and Free Thyroxine Index (FTI)
T3 uptake: measure of how well T3 binds to proteins; used to calculate FTI when binding proteins are abnormal.
FTI (Free Thyroxine Index) is an estimated index of thyroid status when binding proteins are abnormal, often calculated as:
Interpretation of FTI:
Increased FTI suggests hyperthyroidism; decreased FTI suggests hypothyroidism; used when binding abnormalities confound direct measurements (e.g., during pregnancy).
Antibody testing in thyroid disease
Thyroid peroxidase antibody (anti-TPO) / thyroid microsomal antibody (TMAB): autoantibody against thyroperoxidase; common in Hashimoto's; may be present in Graves' (less specific for Graves).
Thyroglobulin antibodies: bind thyroglobulin; can inhibit thyroid hormone synthesis; more common in Hashimoto's.
Antithyrotropin receptor antibody (TRAB) or TSH receptor antibodies (TSI): stimulates TSH receptor; typical in Graves' disease; promotes increased T3/T4 production.
Special antibody notes
TRAB/TSI positivity supports Graves' disease diagnosis in the appropriate clinical context.
TMAB and anti-TPO are more associated with Hashimoto's but must be interpreted with other lab results and signs.
TRH stimulation test (historical, less commonly used now)
Purpose: differentiate hypothalamic (tertiary) from pituitary (secondary) causes of hypothyroidism when unclear.
Procedure: measure baseline TSH, inject TRH, measure TSH at 15, 30, and 60 minutes post-injection.
Expected patterns:
Primary hypothyroidism: TSH remains elevated at 30 minutes (and later).
Normal individual: typical rise and fall pattern (squares in gray in the provided slide).
Hypothalamic (tertiary) hypothyroidism: gradual rise pattern (triangle) indicating inadequate TRH supply.
Pituitary (secondary) hypothyroidism: blunted or absent TSH response to TRH (line with Xs).
Note: TRH stimulation is rarely necessary with modern, sensitive TSH assays, but remains a teaching tool for differentiating hypothalamic vs pituitary origins.
Signs and symptoms: quick reference (opposites)
Hyperthyroidism vs hypothyroidism symptoms (illustrative contrasts):
Tachycardia vs bradycardia
Weight loss vs weight gain
Heat intolerance vs cold intolerance
Tremor, anxiety, sweating vs fatigue, lethargy
Goiter can be present in both hyper- and hypothyroidism
Quick clinical correlations and review points
Graves' disease is the prototypical primary hyperthyroidism and the most common cause of thyrotoxicosis.
The hallmark lab pattern for Graves'/primary hyperthyroidism: high T3/T4, low or undetectable TSH, TRAB positive.
Secondary hyperthyroidism presents with high TSH and high T3/T4; hypothalamic feedback reduces TRH, but pituitary overproduction dominates.
Primary hypothyroidism shows high TSH with low T3/T4; autoimmune Hashimoto's is a leading cause; anti-TPO and anti-thyroglobulin antibodies common.
Secondary hypothyroidism shows low TSH with low T3/T4; panhypopituitarism is a potential cause; TRH may be elevated as compensation.
Tertiary hypothyroidism involves the hypothalamus (low TRH), leading to low TSH and low T3/T4.
Congenital hypothyroidism detected via newborn screening is critical to prevent irreversible neurodevelopmental damage; treatment is lifelong hormone replacement.
Laboratory testing pathway typically starts with TSH (sensitive assay), followed by measurements of free/total T4 and free/total T3 to define primary vs secondary causes.
The relationship between TBG and total thyroid hormone levels explains why total T4/T3 can be misleading in pregnancy, estrogen therapy, or other states altering binding proteins; FTI can help interpret status when binding proteins are abnormal.
Antibody testing (anti-TPO, anti-thyroglobulin, TRAB) helps differentiate Hashimoto's from Graves' and supports the clinical picture.
The TRH stimulation test is a historical tool but can still aid in distinguishing hypothalamic vs pituitary origins when modern assays are inconclusive.
Practical implications: management of Graves' includes symptom control (beta blockers), reduction of hormone synthesis (methimazole), potential thyroid ablation (radioactive iodine), and sometimes surgery; hypothyroidism management centers on lifelong thyroid hormone replacement with levothyroxine.
Real-world relevance: thyroid hormones are essential for neurological development in infants and for metabolic regulation throughout life; misdiagnosis or delayed treatment can lead to significant morbidity.
Summary contrasts (quick reference)
Primary hyperthyroidism: ↑ T3/T4, ↓ TSH; Graves' disease is common; TRAB positive.
Secondary hyperthyroidism: ↑ T3/T4, ↑ or inappropriately normal/low TSH; pituitary origin; TRH may be suppressed.
Primary hypothyroidism: ↓ T3/T4, ↑ TSH; Hashimoto's common; anti-TPO/anti-thyroglobulin positive.
Secondary hypothyroidism: ↓ T3/T4, ↓ TSH; pituitary origin; possible panhypopituitarism.
Tertiary hypothyroidism: ↓ TRH, ↓ TSH, ↓ T3/T4.
Congenital hypothyroidism: newborn screening essential; treat with lifelong hormone replacement.